Globe Newswire

Saxena White P.A. Files Securities Fraud Class Action Against Vestis Corporation May 17, 2024 04:13PM

BOCA RATON, Fla., May 17, 2024 (GLOBE NEWSWIRE) --  Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the Northern District of Georgia against Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) and certain of its executive officers (collectively, “Defendants”). The Class Action asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934... (continue reading...)

PrimeEnergy Resources Corporation (PNRG) Announces First Quarter Results May 17, 2024 04:10PM

HOUSTON, May 17, 2024 (GLOBE NEWSWIRE) -- PrimeEnergy Resources Corporation (PNRG) Announces First Quarter Results:

Oil and gas production volumes for the three months ended March 31, 2024 and 2023:

 Quarter ended March 31,IncreaseIncrease 20242023Oil production (barrels)431,000193,000238,000123%Natural gas production (Mcf)1,157,000801,000356,00044%Natural gas liquids production (barrels)206,000106,000100,00094%      

Total assets at March 31, 2024 were... (continue reading...)

OceanPal Inc. Announces Results of 2024 Annual Meeting of Shareholders May 17, 2024 04:10PM

ATHENS, Greece, May 17, 2024 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, today announced that the Company’s Annual Meeting of Shareholders (the “Meeting”) was duly held on May 17, 2024, in virtual format only via the Internet.

At the Meeting, each of the following proposals, which are set forth in more detail in the Notice of Annual Meeting of Shareholders and the... (continue reading...)

Virios Therapeutics Announces Proposed Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study May 17, 2024 04:10PM

ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), today announced that it intends to offer and sell up to $2.1 million in shares of its common stock in a public offering. All shares of common stock... (continue reading...)

QCR Holdings, Inc. Announces Annual Meeting Results and a Cash Dividend of $0.06 Per Share May 17, 2024 04:05PM

MOLINE, Ill., May 17, 2024 (GLOBE NEWSWIRE) -- QCR Holdings, Inc. (NASDAQ: QCRH) today announced the election of four Class I directors at the Company’s annual meeting of its stockholders. The directors, Mary Kay Bates, John-Paul E. Besong, Todd A. Gipple, and Donna J. Sorenson, were re-elected to three-year terms.

Additionally, on May 15, 2024, the Company’s Board of Directors declared a cash dividend of $0.06 per share payable on July 3, 2024, to holders of... (continue reading...)